Patents by Inventor Roberto BASSI

Roberto BASSI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Filter press with multi-function robot for maintenance, tracking and wear control of filtering septa
    Publication number: 20240075412
    Abstract: A filter press (100) is described comprising: a plurality of filtration chambers (155) each of which is delimited by two mutually facing filtering septa (140, 145) interposed between a pair of containment plates (105), a movement apparatus adapted to move each pair of containment plates (105) between a closed configuration and an open configuration, an inlet hydraulic circuit of the liquid to be filtered, an outlet hydraulic circuit of the filtered liquid, and a washing robot (400) adapted to wash the filtering septa (140, 145) that delimit each filtration chamber (155), wherein said washing robot (400) comprises: a trolley (405) adapted to move along a longitudinal direction (A) with respect to the containment plates (105), a bar (445) installed on the trolley (405) and movable relative thereto in a transverse direction with respect to the longitudinal direction (A), and a plurality of nozzles (450) installed on said bar (445) to dispense jets of a washing liquid toward said filtering septa (140, 145), the f
    Type: Application
    Filed: January 14, 2022
    Publication date: March 7, 2024
    Inventors: Andrea BASSI, Davide COLLINI, Roberto DARDI
  • METHODS RELATED TO THE TREATMENT OF IGA NEPHROPATHY
    Publication number: 20230210948
    Abstract: The present disclosure relates to methods related to the treatment of IgA nephropathy. More specifically, the present disclosure relates to methods for treating a patient having IgA nephropathy (IgAN), to methods for reducing the serum Gd-IgA1 level in a patient having IgA nephropathy (IgAN), to methods for reducing the proteinuria in a patient having IgA nephropathy, to methods for reducing the serum Gd-IgA1 level and the proteinuria in a patient having IgA nephropathy, and further related disclosure.
    Type: Application
    Filed: December 2, 2022
    Publication date: July 6, 2023
    Inventors: Stephen Daniel WAX, Roberto BASSI, Hans GUEHRING, Christopher TEHLIRIAN, Amy Hui-Chien KAO
  • PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY
    Publication number: 20220184009
    Abstract: Embodiments herein disclose methods relating to diabetic nephropathy (DN); methods for preventing the onset and also for preventing the progressing of DN, as well as the treatment of DN in diabetic subjects comprising administering reparixin and/or ladarixin which are inhibitors of CXCL8 receptor CXCR1 and CXCR2 activation.
    Type: Application
    Filed: February 24, 2022
    Publication date: June 16, 2022
    Applicants: THE CHILDREN'S MEDICAL CENTER CORPORATION, DOMPE FARMACEUTICI S.P.A.
    Inventors: Paolo FIORINA, Roberto BASSI, Andrea VERGANI, Marcello ALLEGRETTI
  • Prevention and treatment of diabetic nephropathy
    Patent number: 11291641
    Abstract: Embodiments herein disclose methods relating to diabetic nephropathy (DN); methods for preventing the onset and also for preventing the progressing of DN, as well as the treatment of DN in diabetic subjects comprising administering reparixin and/or ladarixin which are inhibitors of CXCL8 receptor CXCR1 and CXCR2 activation.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: April 5, 2022
    Assignees: THE CHILDREN'S MEDICAL CENTER CORPORATION, DOMPE FARMACEUTICI S.P.A.
    Inventors: Paolo Fiorina, Roberto Bassi, Andrea Vergani, Marcello Allegretti
  • TRANSGENIC MICROALGAE FOR THE PRODUCTION OF PLANT CELL WALL DEGRADING ENZYMES HAVING HEAT-STABLE CELLULOLYTIC ACTIVITY
    Publication number: 20210395702
    Abstract: The present invention relates to transgenic microalgae for the production of cell wall degradative enzymes having a heat-stable cellulolytic activity (HCWDEs) and their relative uses in the biodegradation of cellulose or lignocellulose sources in the industrial field.
    Type: Application
    Filed: July 30, 2019
    Publication date: December 23, 2021
    Inventors: Roberto BASSI, Luca DALL'OSTO, Manuel BENEDETTI
  • METHODS FOR THE USE OF GALECTIN 3 BINDING PROTEIN DETECTED IN THE URINE FOR MONITORING THE SEVERITY AND PROGRESSION OF LUPUS NEPHRITIS
    Publication number: 20190310250
    Abstract: Embodiments of the present invention describe compositions and methods incorporating the measurement of LGALS3BP in the urine of patients diagnosed with lupus nephritis (LN) in order to monitor the severity and progression of said LN.
    Type: Application
    Filed: December 18, 2017
    Publication date: October 10, 2019
    Inventors: Lukas Shinji OKITSU, Jaromir VLACH, Nuruddeen Lewis, Julie DEMARTINO, Roberto BASSI, Wen-Rong LIE
  • PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY
    Publication number: 20190224148
    Abstract: Embodiments herein disclose methods relating to diabetic nephropathy (DN); methods for preventing the onset and also for preventing the progressing of DN, as well as the treatment of DN in diabetic subjects comprising administering reparixin and/or ladarixin which are inhibitors of CXCL8 receptor CXCR1 and CXCR2 activation.
    Type: Application
    Filed: October 3, 2017
    Publication date: July 25, 2019
    Applicants: THE CHILDREN'S MEDICAL CENTER CORPORATION, DOMPE FARMACEUTICI S.P.A.
    Inventors: Paolo FIORINA, Roberto BASSI, Andrea VERGANI, Marcello ALLEGRETTI